Ali Shahraki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ali Shahraki has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Zahra Zakeri
3 shared publicationsMehdi Ravandeh
Medicinal and Ornamental Plants Research Institute University of Sistan and Baluchestan Zahedan IR Iran
2 shared publicationsAr Rezazehi
1 shared publicationGellare Shahryari
Department of Biology Faculty of Sciences University of Sistan and Baluchestan Zahedan IR Iran
1 shared publicationHaniyeh Soheil Beygi
Department of Biology, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran
1 shared publicationMahtab Mollashahi
Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman
1 shared publication
Latest Publications
- 31 December 2025
- Published by Elsevier in Brain Research
- Vol. 1874, 150137
Identification of hub genes and signaling pathways as possible therapeutic targets in human glioblastoma: evidenced by bioinformatics analysis
- 31 December 2025
- Published by Elsevier in Brain Research
- Vol. 1874, 150137
Identification of hub genes and signaling pathways as possible therapeutic targets in human glioblastoma: evidenced by bioinformatics analysis
- 15 February 2021
- Published by Wolters Kluwer Health in Behavioural Pharmacology
- Vol. 32 (4) , 286-294
Activation of L-type calcium channels and attenuation of oxidative stress are involved in the improving effect of methyl jasmonate on learning and memory and its anxiolytic property in rats
The present study was designed to evaluate the effect of plant bioactive compound methyl jasmonate on learning and memory, anxiety-like behaviors, and brain oxidative stress in rats. It has been indicated that methyl jasmonate stimulates calcium-binding protein expression and increases intracellular calcium (Ca2+). Therefore, we investigated the potential role of L-type calcium channel on methyl jasmonate effects. The animals were intracerebroventriculary (i.c.v.) injected with different doses of methyl jasmonate (0.5, 2.5, and 5 µg/rat). L-type calcium channel blocker (nifedipine 5 µg/rat, i.c.v.) was injected 30 min before methyl jasmonate (5 µg/rat). Shuttle box apparatus was used to evaluate passive avoidance memory. Anxiety-like behaviors were assessed by open field and elevated plus maze tests. Lastly, oxidative stress-related indices were assessed in hippocampus and prefrontal cortex. The data showed that methyl jasmonate dose-dependently could improve passive avoidance learning and memory and reduce anxiogenic behaviors. The methyl jasmonate effects were significantly prevented by nifedipine. Furthermore, central microinjection of methyl jasmonate significantly decreased hydrogen peroxide concentration, and increased reactive oxygen species scavenger activity (catalase and peroxide enzymes) in rats’ hippocampus as well as prefrontal cortex. Indeed, the results indicated that the beneficial effects of methyl jasmonate on learning and memory and anxiety might be partly associated with L-type calcium channel and partly on the inhibition of oxidant indices.
- 15 February 2021
- Published by Wolters Kluwer Health in Behavioural Pharmacology
- Vol. 32 (4) , 286-294
Activation of L-type calcium channels and attenuation of oxidative stress are involved in the improving effect of methyl jasmonate on learning and memory and its anxiolytic property in rats
The present study was designed to evaluate the effect of plant bioactive compound methyl jasmonate on learning and memory, anxiety-like behaviors, and brain oxidative stress in rats. It has been indicated that methyl jasmonate stimulates calcium-binding protein expression and increases intracellular calcium (Ca2+). Therefore, we investigated the potential role of L-type calcium channel on methyl jasmonate effects. The animals were intracerebroventriculary (i.c.v.) injected with different doses of methyl jasmonate (0.5, 2.5, and 5 µg/rat). L-type calcium channel blocker (nifedipine 5 µg/rat, i.c.v.) was injected 30 min before methyl jasmonate (5 µg/rat). Shuttle box apparatus was used to evaluate passive avoidance memory. Anxiety-like behaviors were assessed by open field and elevated plus maze tests. Lastly, oxidative stress-related indices were assessed in hippocampus and prefrontal cortex. The data showed that methyl jasmonate dose-dependently could improve passive avoidance learning and memory and reduce anxiogenic behaviors. The methyl jasmonate effects were significantly prevented by nifedipine. Furthermore, central microinjection of methyl jasmonate significantly decreased hydrogen peroxide concentration, and increased reactive oxygen species scavenger activity (catalase and peroxide enzymes) in rats’ hippocampus as well as prefrontal cortex. Indeed, the results indicated that the beneficial effects of methyl jasmonate on learning and memory and anxiety might be partly associated with L-type calcium channel and partly on the inhibition of oxidant indices.
- Open Access
- 25 March 2020
- Published by Brieflands in Shiraz E-Medical Journal
- Vol. 21 (5)
A Survey of the Effects of Diosmin on Learning and Memory Following the Use of Paraquat Herbicide Poisoning in a Model of Rats
Exposure to herbicide paraquat (PQT) is a potential risk factor for cognitive impairment. Many cognitive behaviors, including spatial memory, passive avoida ...
- 25 March 2020
- Published by Brieflands in Shiraz E-Medical Journal
- Vol. 21 (5)
Open AccessA Survey of the Effects of Diosmin on Learning and Memory Following the Use of Paraquat Herbicide Poisoning in a Model of Rats
Exposure to herbicide paraquat (PQT) is a potential risk factor for cognitive impairment. Many cognitive behaviors, including spatial memory, passive avoida ...
- Open Access
- 25 June 2016
- Published by Brieflands in Shiraz E-Medical Journal
- Vol. 17 (6)
Elevated Serum Interleukin-23 and Interleukin-6 Levels in Schizophrenic Patients Compared to Those in Healthy Controls
Background: Various factors, including genetic, psychological, environmental, and immune dysfunction, may contribute to susceptibility to schizophrenia. Due to several reports regarding abnormal cytokine production, abnormal cytokine concentrations and their receptors in peripheral blood and cerebrospinal fluid, activation of the inflammatory response system, and altered levels of different cytokines in acute schizophrenia have been studied in recent years. Objectives: The purpose of this study was to examine interleukin-6 (IL-6) and IL-23 levels in schizophrenic patients versus those of healthy controls. Patients and Methods: In this case–control study, serum levels of IL-6 and IL-23 of 30 schizophrenic patients and 20 age- and gender-matched healthy controls were measured using an enzyme-linked immunosorbent assay (ELISA). The serum levels of these cytokines were measured in schizophrenic patients experiencing their first episode who had not taken any psychotic drugs for at least 2 months prior to the study. Statistical analysis was performed using SPSS software, version 17. IL levels showed a non-Gaussian distribution. The statistical analysis was performed using appropriate statistical tests, including the Kruskal-Wallis or Mann–Whitney test. Results: Serum IL-23 levels of schizophrenic patients were significantly higher (696 ± 132 pg/mL) than those of the control subjects (313 ± 33 pg/mL) (P = 0.007). Serum IL-6 levels of the schizophrenic patients were also significantly higher than those of the controls (5.28 ± 1.1 and 2.54 ± 0.32 pg/mL, respectively; P = 0.01). Conclusions: These findings indicate that immune system activation might be involved in the pathophysiology of schizophrenia. Keywords: Schizophrenia; Immune System; Interleukin-6; Interleukin-23
- 25 June 2016
- Published by Brieflands in Shiraz E-Medical Journal
- Vol. 17 (6)
Open AccessElevated Serum Interleukin-23 and Interleukin-6 Levels in Schizophrenic Patients Compared to Those in Healthy Controls
Background: Various factors, including genetic, psychological, environmental, and immune dysfunction, may contribute to susceptibility to schizophrenia. Due to several reports regarding abnormal cytokine production, abnormal cytokine concentrations and their receptors in peripheral blood and cerebrospinal fluid, activation of the inflammatory response system, and altered levels of different cytokines in acute schizophrenia have been studied in recent years. Objectives: The purpose of this study was to examine interleukin-6 (IL-6) and IL-23 levels in schizophrenic patients versus those of healthy controls. Patients and Methods: In this case–control study, serum levels of IL-6 and IL-23 of 30 schizophrenic patients and 20 age- and gender-matched healthy controls were measured using an enzyme-linked immunosorbent assay (ELISA). The serum levels of these cytokines were measured in schizophrenic patients experiencing their first episode who had not taken any psychotic drugs for at least 2 months prior to the study. Statistical analysis was performed using SPSS software, version 17. IL levels showed a non-Gaussian distribution. The statistical analysis was performed using appropriate statistical tests, including the Kruskal-Wallis or Mann–Whitney test. Results: Serum IL-23 levels of schizophrenic patients were significantly higher (696 ± 132 pg/mL) than those of the control subjects (313 ± 33 pg/mL) (P = 0.007). Serum IL-6 levels of the schizophrenic patients were also significantly higher than those of the controls (5.28 ± 1.1 and 2.54 ± 0.32 pg/mL, respectively; P = 0.01). Conclusions: These findings indicate that immune system activation might be involved in the pathophysiology of schizophrenia. Keywords: Schizophrenia; Immune System; Interleukin-6; Interleukin-23
- Open Access
- 28 February 2016
- Published by Brieflands in Shiraz E-Medical Journal
- Vol. 17 (2)
Investigation on Serum Levels of Interleukin-18 and Interleukin-6 in Patients With Dermatomyositis and Polymyositis
Background: Dermatomyositis (DM) and polymyositis (PM) are common forms of idiopathic inflammatory myopathy which are characterized by muscle inflammation with an unknown cause. Immune cells infiltrate myofibrils and endomysial capillaries, which leads to damage of muscle fibers through the production of humoral factors and different cytokines. Objectives: Increased IL-18 and IL-6 serum levels have been reported in a variety of autoimmune diseases, including rheumatoid arthritis and inflammatory bowel disease. The purpose of this study was to evaluate IL-18 and IL-6 serum levels in DM and PM patients compared to a healthy control group. Patients and Methods: In this cross-sectional study, 15 patients with DM, 5 patients with PM, and 20 healthy control subjects were recruited. The levels of serum IL-18 and IL-6 in patients and control groups were measured by using ELISA assay. Blood tests were taken to determine the levels of C-reactive protein (CRP) and creatine kinase (CK) and were measured by standard methods. Statistical analyses were performed using the Mann-Whitney U-test with a non-Gaussian population using SPSS 19 software. Results: IL-18 levels were significantly higher in DM patients and PM patients before treatment compared to healthy control subjects (P = 0.001, P = 0.01, respectively). There were no significant differences between DM and PM patients before treatment with healthy controls for IL-6 serum levels (P = 0.51, P = 0.43, respectively). Conclusions: Serum IL-18 contributes to the immunopathogenesis of DM and PM and would be a useful marker for the diagnosis and treatment of diseases. IL-6 has a less pivotal role in the pathology of DM and PM. Keywords: Dermatomyositis; Polymyositis; Interleukin-18; Interleukin-6
- 28 February 2016
- Published by Brieflands in Shiraz E-Medical Journal
- Vol. 17 (2)
Open AccessInvestigation on Serum Levels of Interleukin-18 and Interleukin-6 in Patients With Dermatomyositis and Polymyositis
Background: Dermatomyositis (DM) and polymyositis (PM) are common forms of idiopathic inflammatory myopathy which are characterized by muscle inflammation with an unknown cause. Immune cells infiltrate myofibrils and endomysial capillaries, which leads to damage of muscle fibers through the production of humoral factors and different cytokines. Objectives: Increased IL-18 and IL-6 serum levels have been reported in a variety of autoimmune diseases, including rheumatoid arthritis and inflammatory bowel disease. The purpose of this study was to evaluate IL-18 and IL-6 serum levels in DM and PM patients compared to a healthy control group. Patients and Methods: In this cross-sectional study, 15 patients with DM, 5 patients with PM, and 20 healthy control subjects were recruited. The levels of serum IL-18 and IL-6 in patients and control groups were measured by using ELISA assay. Blood tests were taken to determine the levels of C-reactive protein (CRP) and creatine kinase (CK) and were measured by standard methods. Statistical analyses were performed using the Mann-Whitney U-test with a non-Gaussian population using SPSS 19 software. Results: IL-18 levels were significantly higher in DM patients and PM patients before treatment compared to healthy control subjects (P = 0.001, P = 0.01, respectively). There were no significant differences between DM and PM patients before treatment with healthy controls for IL-6 serum levels (P = 0.51, P = 0.43, respectively). Conclusions: Serum IL-18 contributes to the immunopathogenesis of DM and PM and would be a useful marker for the diagnosis and treatment of diseases. IL-6 has a less pivotal role in the pathology of DM and PM. Keywords: Dermatomyositis; Polymyositis; Interleukin-18; Interleukin-6
- Open Access
- 18 October 2015
- Published by Brieflands in Gene, Cell and Tissue
- Vol. 2 (4)
Serum Levels of Interleukin-27 and Interleukin-33 in Patients With Dermatomyositis and Polymyositis Compared to Healthy Control Subjects
Background: In some autoimmune diseases such as rheumatoid arthritis (RA), Interleukin-27 (IL-27) and IL-33 levels are increased. These observations suggest that IL-27 and IL-33 may have a role in the pathogenesis of polymyositis/dermatomyositis (PM/DM). Objectives: The aim of this study was to assess IL-27 and IL-33 levels in PM/DM patients compared to healthy control subjects. Patients and Methods: Twenty patients with DM and nine patients with PM were recruited in this study. Twenty-nine healthy controls whose age and gender were matched with the patients were also recruited. Serum IL-27 and IL-33 was measured by the Enzyme-Linked Immunosorbent Assay (ELISA). Results: The serum levels of IL-27 in patients with DM and PM were higher than those of healthy controls. There were no significant differences in serum levels of IL-33 in patients with DM and PM compared to the healthy control group. Conclusions: These data indicate that IL-27 might be selectively involved in the pathogenesis of DM and PM. However, IL-33 does not appear to be influenced. Keywords: Dermatomyositis; Polymyositis; Interleukin-27; Interleukin-33
- 18 October 2015
- Published by Brieflands in Gene, Cell and Tissue
- Vol. 2 (4)
Open AccessSerum Levels of Interleukin-27 and Interleukin-33 in Patients With Dermatomyositis and Polymyositis Compared to Healthy Control Subjects
Background: In some autoimmune diseases such as rheumatoid arthritis (RA), Interleukin-27 (IL-27) and IL-33 levels are increased. These observations suggest that IL-27 and IL-33 may have a role in the pathogenesis of polymyositis/dermatomyositis (PM/DM). Objectives: The aim of this study was to assess IL-27 and IL-33 levels in PM/DM patients compared to healthy control subjects. Patients and Methods: Twenty patients with DM and nine patients with PM were recruited in this study. Twenty-nine healthy controls whose age and gender were matched with the patients were also recruited. Serum IL-27 and IL-33 was measured by the Enzyme-Linked Immunosorbent Assay (ELISA). Results: The serum levels of IL-27 in patients with DM and PM were higher than those of healthy controls. There were no significant differences in serum levels of IL-33 in patients with DM and PM compared to the healthy control group. Conclusions: These data indicate that IL-27 might be selectively involved in the pathogenesis of DM and PM. However, IL-33 does not appear to be influenced. Keywords: Dermatomyositis; Polymyositis; Interleukin-27; Interleukin-33
- Open Access
- 14 February 2013
- Published by Brieflands in Health Scope
- Vol. 1 (4) , 173-178
Comparative Survey on the Essential Oil Composition and Antioxidant Activity of Aqueous Extracts From Flower and Stem of Achillea Wilhelmsii From Taftan (Southeast of Iran)
Background: Achillea wilhelmsii (Asteraceae) is a Permanent herb, belongs to the genus Achillea (Compositae) Which grows wild in some regions of Iran including Taftan area of Sistan and Baluchestan, in southeast of Iran. Objectives: The purpose of this study was to determine the comparative chemical composition and antioxidant activities of the essential oils extracted from the flowers, stem and leaves of Achillea wilhelmsii. Material and Methods: In this study, the chemical composition of essential oils of the flower and stem of Achillea wilhelmsii from Taftan were obtained by the hydrodistillation method and analyzed by gas chromatography and gas chromatography mass spectroscopy. Results: Sixty one compounds were identified in the essential oil of the flower. The major compounds were Camphor (27.99%), Sabinyl acetate (6.56%), Terpinene-4-ol (6.43%) Camphene (6.43%) and Alpha-Pinene (5.47%). Forty eight compounds were identified in the essential oil of the stem and leaves, which the major compounds were Camphor (34.49%), Alpha-Pinene (8.16%), Camphene (7.87%), Terpinene-4-ol (5.70%), 1,8-Cineole (3.32%). In addition, the antioxidant activity of ethanolic extract was evaluated using the 1, 1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method. Conclusions: According to antioxidant activity outcomes, the amount of IC50s of aqueous extracts of flower and stem and also butylated hydroxyl toluene (BHT) as standard were 232.34, 63.25 and 45.59 ppm respectively. Ultimately, it was highlighted that antioxidant activity of aqueous extract of flower was weaker than stem. Keywords: Achillea wilhelmsii; Essential Oil; Camphor; Antioxidant Activity
- 14 February 2013
- Published by Brieflands in Health Scope
- Vol. 1 (4) , 173-178
Open AccessComparative Survey on the Essential Oil Composition and Antioxidant Activity of Aqueous Extracts From Flower and Stem of Achillea Wilhelmsii From Taftan (Southeast of Iran)
Background: Achillea wilhelmsii (Asteraceae) is a Permanent herb, belongs to the genus Achillea (Compositae) Which grows wild in some regions of Iran including Taftan area of Sistan and Baluchestan, in southeast of Iran. Objectives: The purpose of this study was to determine the comparative chemical composition and antioxidant activities of the essential oils extracted from the flowers, stem and leaves of Achillea wilhelmsii. Material and Methods: In this study, the chemical composition of essential oils of the flower and stem of Achillea wilhelmsii from Taftan were obtained by the hydrodistillation method and analyzed by gas chromatography and gas chromatography mass spectroscopy. Results: Sixty one compounds were identified in the essential oil of the flower. The major compounds were Camphor (27.99%), Sabinyl acetate (6.56%), Terpinene-4-ol (6.43%) Camphene (6.43%) and Alpha-Pinene (5.47%). Forty eight compounds were identified in the essential oil of the stem and leaves, which the major compounds were Camphor (34.49%), Alpha-Pinene (8.16%), Camphene (7.87%), Terpinene-4-ol (5.70%), 1,8-Cineole (3.32%). In addition, the antioxidant activity of ethanolic extract was evaluated using the 1, 1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method. Conclusions: According to antioxidant activity outcomes, the amount of IC50s of aqueous extracts of flower and stem and also butylated hydroxyl toluene (BHT) as standard were 232.34, 63.25 and 45.59 ppm respectively. Ultimately, it was highlighted that antioxidant activity of aqueous extract of flower was weaker than stem. Keywords: Achillea wilhelmsii; Essential Oil; Camphor; Antioxidant Activity
- 5 March 2012
- Published by Brieflands in Health Scope
- Vol. 1 (4) , 171-176
Comparative Survey on the Essential Oil Composition and Antioxidant Activity of Aqueous Extracts From Flower and Stem of Achillea Wilhelmsii From Taftan (Southeast of Iran)
Comparative Survey on the Essential Oil Composition and Antioxidant Activity of Aqueous Extracts From Flower and Stem of Achillea Wilhelmsii From Taftan (Southeast of Iran) - Health Scope - - DOCS
- 5 March 2012
- Published by Brieflands in Health Scope
- Vol. 1 (4) , 171-176
Comparative Survey on the Essential Oil Composition and Antioxidant Activity of Aqueous Extracts From Flower and Stem of Achillea Wilhelmsii From Taftan (Southeast of Iran)
Comparative Survey on the Essential Oil Composition and Antioxidant Activity of Aqueous Extracts From Flower and Stem of Achillea Wilhelmsii From Taftan (Southeast of Iran) - Health Scope - - DOCS